Back to search

Article

Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers

2022-05-13

Abstract excerpt

<title>Abstract</title> <p>Personalized and tumor-informed, circulating tumor DNA (ctDNA) analysis allows for postoperative risk stratification in patients with curatively treated esophagogastric cancers (EGC). In this retrospective analysis of real-world data, ctDNA levels were analyzed in 295 EGC patients using a personalized multiplex PCR-based next generation sequencing assay. Postoperative ctDNA was signific...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba7584c8-32f0-588c-ab2a-2fc334df4e7c
DOI
10.21203/rs.3.rs-1581524/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersDOI 10.21203/rs.3.rs-1581524/v1
Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid TumorsSemantic proximity
Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancerSemantic proximity
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerSemantic proximity
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancersSemantic proximity
Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stages I-III colorectal cancerSemantic proximity
Analysis of the clinical value of postoperative circulating tumor DNA (ctDNA) within the first month for resected colorectal cancer in a real-world.Semantic proximity
Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.Semantic proximity
Development of circulating tumour DNA analysis for gastrointestinal cancersSemantic proximity
A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.Semantic proximity
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studySemantic proximity
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.